Literature DB >> 30636069

Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?

Katharina Puetz1, Elfriede Bollschweiler2,3, Robert Semrau4, Stefan P Mönig2,5, Arnulf H Hölscher2,3, Uta Drebber1.   

Abstract

AIMS: Neoadjuvant chemoradiation reduces tumour volume and improves the R0 resection rate, followed by extended survival for patients with advanced oesophageal cancer. The degree of tumour regression has high prognostic relevance. To date, there is still no generally accepted tumour regression grading system. The aim of this study was to compare the prognostic discrimination power of different histological regression grading systems: (i) the fibrosis/tumour ratio within the primary tumour (Mandard classification), (ii) the percentage of residual vital tumour cells (VTC) compared to the original primary tumour (Cologne Regression) and (iii) the ypT category, in patients with cT3 carcinoma of the oesophagus after neoadjuvant chemoradiation. METHODS AND
RESULTS: This study included 216 patients with oesophageal cancer clinically staged as cT3NxM0 and treated from 2009 to 2012 with standardised chemoradiation followed by oesophagectomy [median age 62 years, 176 (81%) male and 138 (64%) adenocarcinoma patients]. The subgroup frequencies of the three classification systems were ypT category: ypT0 = 18%, ypT1 = 14%, ypT2 = 23%, ypT3 = 44%, ypT4 = 1%; Mandard classification: TRG1 = 18%, TRG2 = 26%, TRG3 = 24%, TRG4 = 30%, TRG5 = 2%; and Cologne Regression Scale: no tumour = 18%, 1-10% VTC = 27%, 10-50% VTC = 26% and >50% VTC = 29%. The Mandard and Cologne Regression classifications showed better prognostic differentiation for the subgroups than the ypT category. The four-tiered Cologne Regression system had a good prognostic relevance. Comparing results of the re-evaluated Cologne Regression classification with the classification by routine pathological report showed very good inter-rater agreement, with kappa value 0.891.
CONCLUSION: Compared to the original primary tumour, the tumour regression grading system using the percentage of residual vital tumour has prognostic relevance.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  adenocarcinoma; neoadjuvant chemoradiation; oesophageal cancer; regression grading; squamous cell carcinoma

Mesh:

Year:  2019        PMID: 30636069     DOI: 10.1111/his.13811

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer.

Authors:  Elfriede Bollschweiler; Arnulf H Hölscher
Journal:  Ann Transl Med       Date:  2019-09

2.  The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma.

Authors:  D J Crull; M C H Hogenes; R Hoekstra; E M Hendriksen; M J van Det; E A Kouwenhoven
Journal:  Ann Surg Oncol       Date:  2022-01-29       Impact factor: 5.344

3.  The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer.

Authors:  David T Pointer; Jordan A McDonald; Samer A Naffouje; Rutika Mehta; Jason B Fleming; Jacques P Fontaine; Gregory Y Lauwers; Jessica M Frakes; Sarah E Hoffe; Jose M Pimiento
Journal:  J Surg Oncol       Date:  2022-05-16       Impact factor: 2.885

4.  Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients.

Authors:  Ute Warnecke-Eberz; Patrick Plum; Viola Schweinsberg; Uta Drebber; Christiane J Bruns; Dolores T Müller; Arnulf H Hölscher; Elfriede Bollschweiler
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

5.  Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy.

Authors:  Zi-Ning Liu; Yin-Kui Wang; Li Zhang; Yong-Ning Jia; Shan Fei; Xiang-Ji Ying; Yan Zhang; Shuang-Xi Li; Yu Sun; Zi-Yu Li; Jia-Fu Ji
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

6.  Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance.

Authors:  Sonay Kus Öztürk; Ali Al-Kaabi; Maria J Valkema; Cristina Graham Martinez; John-Melle Bokhorst; Camiel Rosman; Heidi Rütten; Carla A P Wauters; Michail Doukas; Joseph Jan-Baptist van Lanschot; Peter D Siersema; Iris D Nagtegaal; Rachel Sofia van der Post
Journal:  Histopathology       Date:  2022-04-06       Impact factor: 7.778

7.  Tumor Regression Grade Predicts Survival in Locally Advanced Gastric Adenocarcinoma Patients with Lymph Node Metastasis.

Authors:  Yilin Tong; Yanmei Zhu; Yan Zhao; Zexing Shan; Jianjun Zhang; Dong Liu
Journal:  Gastroenterol Res Pract       Date:  2020-07-18       Impact factor: 2.260

8.  Esophageal Carcinoma Cuniculatum Diagnosed on Mucosal Biopsies Using a Semiquantitative Histologic Schema: Report of Two Esophagectomy-Confirmed Cases.

Authors:  Xiuli Liu; Dennis Yang; Xuefeng Zhang; Olusola Oduntan
Journal:  Gastroenterology Res       Date:  2020-02-01

9.  Evaluation and Comparison of Predictive Value of Tumor Regression Grades according to Mandard and Becker in Locally Advanced Gastric Adenocarcinoma.

Authors:  Yilin Tong; Yanmei Zhu; Yan Zhao; Zexing Shan; Dong Liu; Jianjun Zhang
Journal:  Cancer Res Treat       Date:  2020-08-10       Impact factor: 4.679

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.